Welcome to the WCN 2023 Interactive Program

Session Description:Session I – Dedicated to the changing scenario in the treatment of migraine with the recent availability of 9 new specific drugs, while providing viable alternatives for those Countries that will not have access to them.Session II – The session will provide up-to date information on cluster headache, a primary headache characterized by an extremely severe pain. A talk will illustrate Medication overuse headache a chronic, disabling but preventable type of headache than can effectively be managed with different modalities. The last talk of the session will address the issue of new onset headache associated to Covid-19, to the worsening of primary headache during and after Covid-19 and to the possible underlying neurobiologySession III – This session is dedicated to the cutting-edge advances in migraine pathophysiology obtained with different approaches. It will illustrate effective tools that are being used to gain more and more insights on the mechanisms underlying this complex disease at different levelsLearning Objectives:1.Attendees will familiarize with the most advanced approaches to the management of migraine.2.They will receive the necessary information to diagnose and manage medication overuse headache, while gathering the awareness that it is a common and debilitating condition that should be, first of all, prevented. Attendees will also be guides to recognize and treat COVID-19 associated headache.3.Attendees will be introduced in the fascinating world of the pre-clinical and clinical modalities of research that are progressively unveiling the complex neurobiology of migraine and identifying more and treatment targets.